# Risk of SDRs Under 3HP and 1HP Regimen for LTBI

> **NCT04094012** · PHASE3 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 490 (actual)

## Conditions studied

- Latent Tuberculosis Infection

## Interventions

- **DRUG:** isoniazid and rifapentine

## Key facts

- **NCT ID:** NCT04094012
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-24
- **Primary completion:** 2023-10-08
- **Final completion:** 2023-12-15
- **Target enrollment:** 490 (ACTUAL)
- **Last updated:** 2023-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04094012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04094012, "Risk of SDRs Under 3HP and 1HP Regimen for LTBI". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04094012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*